Powered by
ANN ARBOR—Officials at Endra Life Sciences Inc. (NASDAQ: NDRA) announced that the company had been issued U.S. Patent 11,147,067 titled, “Method And System For Monitoring Tissue Temperature” from the United …
ANN ARBOR—The German laboratory equipment manufacturer Sartorius AG announced that it would build a 130,000-square-foot plant in Ann Arbor, creating 160 new jobs in product development, operations, and other functions …
ANN ARBOR—The genomics company Genomenon Inc. has announced a partnership with Alexion, a rare disease subsidiary of pharma giant AstraZeneca, that will make critical information needed for the diagnosis and …
ANN ARBOR—The autonomous vehicle developer May Mobility, the Mcity advanced vehicle testing center at the University of Michigan, and Ann Arbor Spark, the economic development agency for Washtenaw and Livingston …
ANN ARBOR—BlueWillow Biologics Inc., a privately held clinical-stage biopharmaceutical company developing intranasal vaccines, announced positive interim results from the Phase 1 clinical trial of BW-1010, its next-generation intranasal anthrax vaccine …
ANN ARBOR—The pharmaceutical firm Esperion Therapeutics Inc. (Nasdaq: ESPR) reported a rise in sales of its novel cholesterol-reducing drugs in the second quarter ended June 30 but still posted a …
ANN ARBOR–A Georgia company has announced plans to offer high-speed gigabit internet service across Michigan’s Upper Peninsula. Highline Internet, a trademark of West Point, Ga.-based ITC Broadband Operating LLC, will …
ANN ARBOR—The Association for Advancing Automation (A3) is hosting the new Automate Preview Series, a program of six executive webinars, starting Sept. 14. The series will outline some of the …
ANN ARBOR—Officials at Coretec Group Inc. (OTC: CRTG), developers of engineered silicon products to improve electronics, announced a new partnership with the Eindhoven University of Technology to advance intellectual property …
ANN ARBOR—Officials at HistoSonics, developer of novel ultrasound therapies, announced today that the first patient has been treated as part of the company’s #HOPE4LIVER Europe Trial, which was approved by …